Inhibitors of human immunodeficiency virus replication

Details for Australian Patent Application No. 2007250427 (hide)

Owner Gilead Sciences, Inc.

Inventors Pesant, Marc; Fenwick, Craig; Boes, Michael; Mason, Stephen; Brochu, Christian; Tsantrizos, Youla S.; Malenfant, Eric

Agent Davies Collison Cave

Pub. Number AU-B-2007250427

PCT Pub. Number WO2007/131350

Priority 60/747,311 16.05.06 US

Filing date 14 May 2007

Wipo publication date 22 November 2007

Acceptance publication date 30 August 2012

International Classifications

C07D 311/08 Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

A61K 31/352 - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/47 - Quinolines

A61P 31/18 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 215/22 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/131350 Priority application(s): WO2007/131350

9 February 2012 Assignment before Grant

  Boehringer Ingelheim International GmbH The application has been assigned to Gilead Sciences, Inc

30 August 2012 Application Accepted

  Published as AU-B-2007250427

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007250429-High-affinity antagonists of ELR-CXC chemokines

2007250390-Stator casing for eccentric worm pumps